Benefit change exercises — what are the practical implications of the IBM case for trustees and employers?
By Ian Gordon
The latest IBM case has implications for employers and trustees when considering changes to members’ pension benefits. But what implications?
The most recent IBM judgment concerned IBM’s Imperial duties, i.e. its obligation to act in good faith to members of its pension schemes.
‘Project Waltz’ was to be a major reform of two of IBM’s UK pension schemes, made against the backdrop of a commitment IBM US had made to investors on Wall Street. The proposed reforms were not unusual, and comprised closing the schemes to future accrual, ensuring that future pay rises were not all pensionable and introducing cost-neutral early retirement factors…
Click on the link below to read the rest of the Wragge Lawrence Graham & Co briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
Wragge Lawrence Graham & Co’s non-contentious engineering and construction experts provide their top 10 tips for executing documents.
Parallel imports: when it is permissible to rebrand goods to the trademark used in the importing EU member state?
The Court of Appeal has returned its judgment in parallel imports case Speciality European Pharma v Doncaster Pharmaceuticals.